Inciardi, PhD JA, Surratt, PhD HL, Stivers, BA Y, Cicero, PhD TJ. FDA approvals of generic drugs: Impact on the diversion of opioid analgesics with a potential for abuse. J of Opioid Management [Internet]. 2018 Jan. 29 [cited 2024 May 3];5(2):81-7. Available from: https://wmpllc.org/ojs/index.php/jom/article/view/927